230 related articles for article (PubMed ID: 38148640)
1. The molecular classification of cancer-associated fibroblasts on a pan-cancer single-cell transcriptional atlas.
Chen B; Chan WN; Xie F; Mui CW; Liu X; Cheung AHK; Lung RWM; Chow C; Zhang Z; Fang C; Yu P; Shi S; Zhou S; Chen G; Wang Z; Wang S; Ding X; Huang B; Liang L; Dong Y; Wong CC; Wu WKK; Cheng ASL; Wong N; Yu J; Lo KW; Tse GMK; Kang W; To KF
Clin Transl Med; 2023 Dec; 13(12):e1516. PubMed ID: 38148640
[TBL] [Abstract][Full Text] [Related]
2. Periostin- and podoplanin-positive cancer-associated fibroblast subtypes cooperate to shape the inflamed tumor microenvironment in aggressive pancreatic adenocarcinoma.
Neuzillet C; Nicolle R; Raffenne J; Tijeras-Raballand A; Brunel A; Astorgues-Xerri L; Vacher S; Arbateraz F; Fanjul M; Hilmi M; Samain R; Klein C; Perraud A; Rebours V; Mathonnet M; Bièche I; Kocher H; Cros J; Bousquet C
J Pathol; 2022 Dec; 258(4):408-425. PubMed ID: 36102377
[TBL] [Abstract][Full Text] [Related]
3. Molecular Features of Cancer-associated Fibroblast Subtypes and their Implication on Cancer Pathogenesis, Prognosis, and Immunotherapy Resistance.
Galbo PM; Zang X; Zheng D
Clin Cancer Res; 2021 May; 27(9):2636-2647. PubMed ID: 33622705
[TBL] [Abstract][Full Text] [Related]
4. Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma.
Neuzillet C; Tijeras-Raballand A; Ragulan C; Cros J; Patil Y; Martinet M; Erkan M; Kleeff J; Wilson J; Apte M; Tosolini M; Wilson AS; Delvecchio FR; Bousquet C; Paradis V; Hammel P; Sadanandam A; Kocher HM
J Pathol; 2019 May; 248(1):51-65. PubMed ID: 30575030
[TBL] [Abstract][Full Text] [Related]
5. Cell-type deconvolution analysis identifies cancer-associated myofibroblast component as a poor prognostic factor in multiple cancer types.
Li B; Pei G; Yao J; Ding Q; Jia P; Zhao Z
Oncogene; 2021 Jul; 40(28):4686-4694. PubMed ID: 34140640
[TBL] [Abstract][Full Text] [Related]
6. Microdissection of cancer-associated fibroblast infiltration subtypes unveils the secreted SERPINE2 contributing to immunosuppressive microenvironment and immuotherapeutic resistance in gastric cancer: A large-scale study integrating bulk and single-cell transcriptome profiling.
Zhang D; Sun R; Di C; Li L; Zhao F; Han Y; Zhang W
Comput Biol Med; 2023 Nov; 166():107406. PubMed ID: 37729702
[TBL] [Abstract][Full Text] [Related]
7. Integrating single-cell and bulk RNA sequencing data unveils antigen presentation and process-related CAFS and establishes a predictive signature in prostate cancer.
Wang W; Li T; Xie Z; Zhao J; Zhang Y; Ruan Y; Han B
J Transl Med; 2024 Jan; 22(1):57. PubMed ID: 38221616
[TBL] [Abstract][Full Text] [Related]
8. Single-cell and spatial transcriptomics reveal POSTN
Chen C; Guo Q; Liu Y; Hou Q; Liao M; Guo Y; Zang Y; Wang F; Liu H; Luan X; Liang Y; Guan Z; Li Y; Liu H; Dong X; Zhang X; Liu J; Xu Q
Clin Transl Med; 2023 Dec; 13(12):e1515. PubMed ID: 38115703
[TBL] [Abstract][Full Text] [Related]
9. Adipose-derived mesenchymal stem cells differentiate into pancreatic cancer-associated fibroblasts in vitro.
Miyazaki Y; Oda T; Mori N; Kida YS
FEBS Open Bio; 2020 Nov; 10(11):2268-2281. PubMed ID: 32931156
[TBL] [Abstract][Full Text] [Related]
10. Cancer-associated Fibroblasts in Bladder Cancer: Origin, Biology, and Therapeutic Opportunities.
Caramelo B; Zagorac S; Corral S; Marqués M; Real FX
Eur Urol Oncol; 2023 Aug; 6(4):366-375. PubMed ID: 36890105
[TBL] [Abstract][Full Text] [Related]
11. Single-cell RNA sequencing reveals a pro-invasive cancer-associated fibroblast subgroup associated with poor clinical outcomes in patients with gastric cancer.
Li X; Sun Z; Peng G; Xiao Y; Guo J; Wu B; Li X; Zhou W; Li J; Li Z; Bai C; Zhao L; Han Q; Zhao RC; Wang X
Theranostics; 2022; 12(2):620-638. PubMed ID: 34976204
[No Abstract] [Full Text] [Related]
12. Deciphering the temporal heterogeneity of cancer-associated fibroblast subpopulations in breast cancer.
Venning FA; Zornhagen KW; Wullkopf L; Sjölund J; Rodriguez-Cupello C; Kjellman P; Morsing M; Hajkarim MC; Won KJ; Erler JT; Madsen CD
J Exp Clin Cancer Res; 2021 May; 40(1):175. PubMed ID: 34016130
[TBL] [Abstract][Full Text] [Related]
13. Clinical and therapeutic relevance of cancer-associated fibroblasts.
Chen Y; McAndrews KM; Kalluri R
Nat Rev Clin Oncol; 2021 Dec; 18(12):792-804. PubMed ID: 34489603
[TBL] [Abstract][Full Text] [Related]
14. Integrated transcriptomic analysis systematically reveals the heterogeneity and molecular characterization of cancer-associated fibroblasts in osteosarcoma.
Liu Y; Han X; Han Y; Bi J; Wu Y; Xiang D; Zhang Y; Bi W; Xu M; Li J
Gene; 2024 May; 907():148286. PubMed ID: 38367852
[TBL] [Abstract][Full Text] [Related]
15. Single-cell and bulk RNA sequencing reveal cancer-associated fibroblast heterogeneity and a prognostic signature in prostate cancer.
Liu W; Wang M; Wang M; Liu M
Medicine (Baltimore); 2023 Aug; 102(32):e34611. PubMed ID: 37565899
[TBL] [Abstract][Full Text] [Related]
16. Dissecting the role of cancer-associated fibroblast-derived biglycan as a potential therapeutic target in immunotherapy resistance: A tumor bulk and single-cell transcriptomic study.
Zheng S; Liang JY; Tang Y; Xie J; Zou Y; Yang A; Shao N; Kuang X; Ji F; Liu X; Tian W; Xiao W; Lin Y
Clin Transl Med; 2023 Feb; 13(2):e1189. PubMed ID: 36772945
[TBL] [Abstract][Full Text] [Related]
17. The collagen landscape in cancer: profiling collagens in tumors and in circulation reveals novel markers of cancer-associated fibroblast subtypes.
Thorlacius-Ussing J; Jensen C; Nissen NI; Cox TR; Kalluri R; Karsdal M; Willumsen N
J Pathol; 2024 Jan; 262(1):22-36. PubMed ID: 37728068
[TBL] [Abstract][Full Text] [Related]
18. Evidence of steady-state fibroblast subtypes in the normal human breast as cells-of-origin for perturbed-state fibroblasts in breast cancer.
Bagger MM; Sjölund J; Kim J; Kohler KT; Villadsen R; Jafari A; Kassem M; Pietras K; Rønnov-Jessen L; Petersen OW
Breast Cancer Res; 2024 Jan; 26(1):11. PubMed ID: 38229104
[TBL] [Abstract][Full Text] [Related]
19. Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment.
Luo H; Xia X; Huang LB; An H; Cao M; Kim GD; Chen HN; Zhang WH; Shu Y; Kong X; Ren Z; Li PH; Liu Y; Tang H; Sun R; Li C; Bai B; Jia W; Liu Y; Zhang W; Yang L; Peng Y; Dai L; Hu H; Jiang Y; Hu Y; Zhu J; Jiang H; Li Z; Caulin C; Park J; Xu H
Nat Commun; 2022 Nov; 13(1):6619. PubMed ID: 36333338
[TBL] [Abstract][Full Text] [Related]
20. Targeting the devil: Strategies against cancer-associated fibroblasts in colorectal cancer.
Chen Y; Liang Z; Lai M
Transl Res; 2024 Apr; 270():81-93. PubMed ID: 38614213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
